---
schema_version: "secwatch.filing_event.v1"
accession: "0001808805-22-000108"
form_type: "8-K/A"
ticker: "NAUT"
cik: "0001808805"
company_name: "Nautilus Biotechnology, Inc."
filed_at: "2022-11-01T23:59:59+00:00"
generated_at: "2026-06-22T19:05:51.594736+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Nautilus appoints Karen Akinsanya to Nominating and Governance Committee

## Summary
- Appointment effective October 27, 2022; committee now includes McIlwain (Chair), Pande, and Akinsanya.
- Akinsanya joined the Board in March 2022; committee assignment was previously undetermined.
- This amendment updates the original 8-K filed March 31, 2022 regarding Akinsanya's directorship.

## SEC filing metadata
- accession: 0001808805-22-000108
- form_type: 8-K/A
- ticker: NAUT
- cik: 0001808805
- company_name: Nautilus Biotechnology, Inc.
- filed_at: 2022-11-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808805/000180880522000108/0001808805-22-000108-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808805/000180880522000108/naut-20220330.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001808805-22-000108
- JSON: https://secwatch.observer/filing/0001808805-22-000108.json
- Plain text: https://secwatch.observer/filing/0001808805-22-000108.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.